We are live on ! Find out more
VCYT icon

Veracyte

48 hedge funds and large institutions have $69.3M invested in Veracyte in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 4848 (0)

0% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 5

0% more repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 13

24% less capital invested

Capital invested by funds: $91.2M → $69.3M (-$21.9M)

Holders
48
Holders Change
Holders Change %
0%
% of All Funds
1.28%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
13
Reduced
13
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
TC
51
TFS Capital
Pennsylvania
-$126K -13,001 Closed
Bank of America
52
Bank of America
North Carolina
-$3.96K -483 -97%
Royal Bank of Canada
53
Royal Bank of Canada
Ontario, Canada
-$1K -52 Closed

VCYT Hedge Fund Activity: Q1 2015 in Review

48 of the 3,752 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q1 2015, worth a combined $69.3M — down 24% from $91.2M a quarter earlier.

Fund positioning in VCYT was balanced in Q1 2015: 5 funds opened new positions, 5 closed out, 13 added to existing stakes and 13 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $1.93M. The largest seller was Great Point Partners, cutting an estimated $3.98M.

  • 48 institutional investors held Veracyte (VCYT) as of Q1 2015, unchanged from Q4 2014.
  • Funds reported $69.3M of Veracyte stock for Q1 2015, down 24% quarter-over-quarter.
  • 5 funds opened new Veracyte positions in Q1 2015 and 5 closed out, a net change of 0 holders.
  • The largest Veracyte buyer in Q1 2015 was Consonance Capital Management, an estimated $1.93M added.
  • The largest Veracyte seller in Q1 2015 was Great Point Partners, an estimated $3.98M sold.

Based on aggregated 13F filings for Q1 2015.